Our own Marlena Fejzo, Phd., has written the new hyperemesis gravidarum (HG) article on NORD! In her article, she outlines the severe symptoms of HG, its etiology, who it affects, and how it should be treated by medical professionals.
NORD (National Organization of Rare Disorders) is a patient service organization that has been serving the rare disease community for over 30 years. They provide patient advocacy such as working with policy makers in Washington DC, mentorship, education, research support, patient assistance programs, and international partnerships with other countries around the globe to ease the burden of rare diseases world wide.
While NORD’s focus is broad in scope, covering over 7,000 rare diseases, here at the HER Foundation, our focus is on one, Hyperemesis Gravidarum. We are the global voice of HG progress. We’re a 501(c)3 nonprofit that provides support, groundbreaking research, advocacy, and education on hyperemesis. Since 2000, we have been the leading source of information on HG and have helped hundreds of thousands of families across the globe.
We still have a long way to go, but with USC geneticist, Dr. Marlena Fejzo, we are one step closer to finding a cure for HG!